OBiO Logo (EUIPO, 05/23/2022)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark OBiO was filed as Figurative mark on 05/23/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/08/2022.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing
| Trademark form | Figurative mark |
| File reference | 018706277 |
| Application date | May 23, 2022 |
| Publication date | July 1, 2022 |
| Entry date | October 8, 2022 |
| Expiration date | May 23, 2032 |
Trademark owner
Building No.19, Lane 908, Ziping Rd., Pudong New District
Shanghai
CN
Shanghai
CN
Trademark representatives
Viale Europa Unita, 171
33100 Udine (UD)
IT
goods and services
5
Chemical preparations for use in dna analysis [medical]; Genetic identity tests comprised of reagents for medical purposes; Preparations for detecting genetic predispositions for medical purposes
35
On-line and off-line advertising, marketing activities of OBiO's main business, especially in laboratory scientific services, process development and manufacturing services for gene therapy vectors, cell therapy products, plasmid DNA and nucleotide drugs, i.e. contract research services and contract development and manufacturing services in gene research and gene therapy; Business monitoring and consulting services, namely, tracking web sites and applications of others to provide strategy, insight, marketing, sales, operation, product design, particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumers, businesses, and market trends and actions; Business management consulting with relation to strategy, marketing, production, personnel and retail sale matters; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Providing marketing information via websites; Business management consulting with relation to strategy, marketing, sales, operation, product design particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumers, businesses, and market trends and actions; Electronic commerce services, namely, providing information about products via telecommunication networks for advertising and sales purposes
42
Testing, inspection, research, process development, or manufacturing services for gene and cell therapy; Providing laboratory research services in the field of gene functional research, drug efficacy research or early development of genetic drugs; Testing services of experimental sample for research purposes; Consulting services in the field of design, planning, and implementation scientific research projects; Product quality testing services for gene therapy products; Filling services for gene therapy products; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of cell and gene therapy; Process development for gene therapy vectors, cell therapy products, plasmid DNA and nucleotide drugs, i.e. contract research services and contract development in gene research and gene therapy
ID: 11018706277